Chiral diamines derived from (R,R)- or (S,S)-1,2-diphenylethylenediamine and (S)- or (R)-2,2′-bis(bromomethyl)-1,1′-binaphthalene perform very well as catalysts in the enantioselective addition of ZnEt2 and ZnMe2 to trifluoroacetophenones, avoiding reduction products, in contrast to the poor results with amino alcohols. Excellent yields (up to 99%) and high enantioselectivity (up to 92%) are achieved with the best ligands. A kinetic study at low temperature (−37 °C) shows that the reduction reaction rate on ligandless ZnEt2 is negligible (2 orders of magnitude slower) compared to the rate of addition reaction on [ZnR2(N−N)]. Using this new procedure, reported fragments of inhibitors of enzyme 11β-HSD1 that are active against obesity and type 2 diabetes mellitus, as well as new unreported modified fragments of these bioactive molecules, were produced efficiently and enantioselectively.